Cancer cells on the wrong path – How adaptations can make cancer treatment more difficult

Each tumor consists of multiple cell types, all of which have distinct characteristics. In addition to determining the course of the disease, these differences between individual cancer cells control the effectiveness of targeted therapies. A team of…

3 Min
More

atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update

 

-Successfully completed Initial Public Offering on Nasdaq raising $258.8 million in gross proceeds, including the underwriters’ over-allotment-

-Received $20 million upfront payment from Otsuka as part of the first major collaboration between a…

12 Min
More

Cystic Fibrosis – Increasing numbers of patients benefit from improved treatment

A clinical trial, conducted by an international team of researchers and co-led by Charité – Universitätsmedizin Berlin, has shown that a triple combination therapy consisting of three known compounds is both safe and effective in cystic fibrosis…

6 Min
More

Insulin Directly Regulates the Circadian Clock in Adipose Tissue

Eating at the wrong time of day disrupts our circadian rhythm and increases the risk of obesity and type 2 diabetes. The team led by PD Dr. Olga Ramich of DIfE, Professor Achim Kramer and Professor Andreas F. H. Pfeiffer of Charité –…

3 Min
More

Nobelpharma signs a License Agreement for ProBioGen’s Vaccine Manufacturing Platform AGE1.CR.pIX®

 

ProBioGen is pleased to announce that Nobelpharma has signed a license agreement for the use of the AGE1.CR.pIX vaccine production platform to develop their lead vaccine. The signing of the agreement is yet another milestone in a series of fruitful…

1 Min
More

Interview with Björn von Siemens, Co-Founder of caresyntax

Björn von Siemens is co-founder and managing director of caresyntax GmbH. The company develops algorithms that analyze risk factors during surgery and provide decision support. The company, based in Berlin and Boston, recently raised 100 million US…

1 Min
More

Eckert & Ziegler Takes over Brazilian Isotope Specialists - Strengthening their Presence in South America

 

Berlin, 2 August 2021. Eckert & Ziegler (ISIN DE0005659700, TecDAX) acquired Ambientis Radioproteção, based in Sao Paulo, Brazil, effective July 31st, 2021 via its subsidiary Eckert & Ziegler Brasil Isotope Solutions Ltda (EZBIS). The business with…

2 Min
More
Show more items